You are here

  • Home
  • Archive
  • Volume 10, Issue Suppl 2
  • 645 Phase I study of adoptive T cell therapy following HER2-pulsed dendritic cell vaccine and pepinemab/trastuzumab in patients with metastatic HER2-positive breast cancer (MBC)

Article metrics

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Clinical Trials In Progress
645 Phase I study of adoptive T cell therapy following HER2-pulsed dendritic cell vaccine and pepinemab/trastuzumab in patients with metastatic HER2-positive breast cancer (MBC)
Free

 

Online download statistics by month:

Online download statistics by month: November 2022 to November 2024

AbstractFullPdf
Nov 2022229015
Dec 202211206
Jan 20238602
Feb 20239803
Mar 20238002
Apr 20237002
May 202376010
Jun 20235602
Jul 20238807
Aug 20236802
Sep 20237203
Oct 20237202
Nov 20237001
Dec 20239206
Jan 20246202
Feb 20245400
Mar 20246802
Apr 20245007
May 20243802
Jun 20245404
Jul 20244802
Aug 20244402
Sep 20244809
Oct 20243004
Nov 20243202
Total1797099